Trustmark Reports Q1 2026 EPS Beat and Lower Credit Provisions, Notes Rise in Nonperforming Assets
summarizeSummary
Trustmark reported increased Q1 2026 net income and EPS, driven by lower credit loss provisions and net interest income growth, though nonperforming assets rose.
check_boxKey Events
-
Q1 2026 Financial Performance Exceeds Prior Year
Net income for Q1 2026 increased to $56.1 million, up 4.6% from $53.6 million in Q1 2025. Basic and diluted EPS rose to $0.95, an increase of 7.95% from $0.88 in the prior year period. Total revenue grew 4.2% to $202.9 million.
-
Significant Decrease in Credit Loss Provisions
The provision for credit losses (PCL) on loans held for investment (LHFI) decreased by 42.3% to $4.7 million in Q1 2026, down from $8.1 million in Q1 2025, primarily due to changes in macroeconomic forecasts and qualitative reserve factors.
-
Increase in Nonperforming Assets
Nonperforming assets increased by 13.9% to $104.0 million at March 31, 2026, compared to $91.3 million at December 31, 2025. This rise was mainly due to 1-4 family mortgage loans and a large commercial credit placed on nonaccrual status.
-
Solid Balance Sheet Growth and Capital Management
Loans held for investment (LHFI) grew 1.5% to $13.878 billion, and total deposits increased 1.4% to $15.713 billion from year-end 2025. The company repurchased $19.8 million of common stock under its $100 million program and maintains strong regulatory capital ratios, exceeding all minimum standards.
auto_awesomeAnalysis
Trustmark Corporation's Q1 2026 results show a positive trend in profitability with an increase in net income and EPS, alongside a significant reduction in credit loss provisions. This detailed quarterly report follows a preliminary 8-K filing on April 28, 2026, providing comprehensive financial statements and management's discussion. While loan and deposit growth remains solid, the notable increase in nonperforming assets warrants close monitoring, indicating potential future credit quality challenges despite the current quarter's lower provisions. The company maintains a strong capital position and continues its stock repurchase program, signaling confidence in its financial health amidst a cautious economic outlook.
At the time of this filing, TRMK was trading at $44.92 on NASDAQ in the Finance sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $33.39 to $45.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.